ConductScience.org, home

Paper840296

Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells.

Virelizier JL and 3 others. Nature, 1977. Cited by 92 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Papers, record 840296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/840296

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells.
PubMed
Journal
Nature
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
92
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Virelizier JLJ L
2Allison ACA C
3Oxford JSJ S
4Schild GCG C

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ViralMajor topic
Influenza A virusMajor topic
Influenza, HumanMajor topic
NucleoproteinsMajor topic
Cell Line
Cell Membrane
Humans
Ribonucleoproteins
Time Factors

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,625,019Polypeptide synthesis in influenza virus-infected cells.Virology1972https://conductscience.org/library/papers/4625019PubMed
3807,637Host defenses against influenza virus: the role of anti-hemagglutinin antibody.J Immunol1975https://conductscience.org/library/papers/807637PubMed
44,914,627Developmental sequence and intracellular sites of synthesis of three structural protein antigens of influenza A2 virus.J Virol1970https://conductscience.org/library/papers/4914627PubMed
54,981,077New virus-specific antigens in cells infected with influenza virus.Virology1969https://conductscience.org/library/papers/4981077PubMed
64,623,638Evidence for a new type-specific structural antigen of the influenza virus particle.J Gen Virol1972https://conductscience.org/library/papers/4623638PubMed
7959,113The role of humoral immunity in host defence against influenza A infection in mice.Postgrad Med J1976https://conductscience.org/library/papers/959113PubMed
84,602,223Movement of virus-induced antigens on the cell surface.Arch Gesamte Virusforsch1973https://conductscience.org/library/papers/4602223PubMed
94,752,847The effect of bursectomy and thymectomy on the course of avian influenza virus infection.Cell Immunol1973https://conductscience.org/library/papers/4752847PubMed
104,543,055Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus.Antonie Van Leeuwenhoek1973https://conductscience.org/library/papers/4543055PubMed
124,998,414The polypeptide composition of influenza A viruses.Virology1971https://conductscience.org/library/papers/4998414PubMed
1314,255,658INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.J Bacteriol1965https://conductscience.org/library/papers/14255658PubMed

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.

PMIDTitleJournalYearIn PapersSource
42,269,835Hijacking the host heparan sulfate-cell-surface ribonucleoproteins (RNPs) scaffold pathway for viral immune evasion.Virol Sin2026https://conductscience.org/library/papers/42269835PubMed
41,659,501The Unexpected Visibility of the SARS-CoV-2 Nucleocapsid Protein Reveals a Hidden Route of Surface Trafficking.bioRxiv2026https://conductscience.org/library/papers/41659501PubMed
40,295,865Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?Npj Viruses2024https://conductscience.org/library/papers/40295865PubMed
38,140,152Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.Vaccines (Basel)2023https://conductscience.org/library/papers/38140152PubMed
37,916,834Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.J Virol2023https://conductscience.org/library/papers/37916834PubMed
37,399,385Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37399385PubMed
35,587,364SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies.Elife2022https://conductscience.org/library/papers/35587364PubMed
35,336,928The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.Viruses2022https://conductscience.org/library/papers/35336928PubMed
34,925,355A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model.Front Immunol2021https://conductscience.org/library/papers/34925355PubMed
33,916,924Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses.Vaccines (Basel)2021https://conductscience.org/library/papers/33916924PubMed
32,811,334Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice.Emerg Microbes Infect2020https://conductscience.org/library/papers/32811334PubMed
32,719,124Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32719124PubMed
32,121,563Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function.Viruses2020https://conductscience.org/library/papers/32121563PubMed
31,993,232Non-neutralizing Antibodies Directed at Conservative Influenza Antigens.Acta Naturae2019https://conductscience.org/library/papers/31993232PubMed
31,379,866Protective Antibodies Against Influenza Proteins.Front Immunol2019https://conductscience.org/library/papers/31379866PubMed
29,701,840A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge.J Infect Dis2018https://conductscience.org/library/papers/29701840PubMed
27,428,437What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.EBioMedicine2016https://conductscience.org/library/papers/27428437PubMed
26,343,187Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.Vaccines (Basel)2015https://conductscience.org/library/papers/26343187PubMed
24,971,078Universal immunity to influenza must outwit immune evasion.Front Microbiol2014https://conductscience.org/library/papers/24971078PubMed
24,109,221Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.J Virol2013https://conductscience.org/library/papers/24109221PubMed

See all 39 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/840296

GET https://conductscience.org/api/papers/v1/840296/cited_by?page=2